Participant perceptions about fracture risk and decisions to initiate osteoporosis pharmacotherapy immediately following attendance at group consult programme for osteoporosis
| Comments | All participants, n (%) (N= 107) | 10-year MOF risk of<20%, n (%) (N= 88) | 10-year MOF risk of ≥20%, n (%) (N= 19) | P-valuea |
|---|---|---|---|---|
| Fracture risk perceptions | ||||
| Felt to be at low risk of fracture | 59 (55.1) | 56 (63.6) | 3 (15.8) | 0.002 |
| Worried about risk of fracture | 44 (41.1) | 33 (37.5) | 11 (57.9) | 0.13 |
| Feel likely to benefit from medication | 28 (26.2) | 19 (21.6) | 9 (47.4) | 0.04 |
| Pharmacotherapy decisions | ||||
| Plan to initiate | 29 (27.1) | 20 (22.7) | 9 (47.4) | 0.003 |
| Undecided | 29 (27.1) | 21 (23.9) | 8 (42.1) | |
| Decline to initiate | 49 (45.8) | 47 (53.4) | 2 (10.5) | |
↵a P-values indicate differences in proportions between those with 10-year MOF risk of <20% and those with risk of ≥20%. MOF = major osteoporotic fracture, calculated using the Fracture Risk Assessment Tool (FRAX).